Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

SELL
$57.89 - $64.73 $17,424 - $19,483
-301 Reduced 7.89%
3,513 $204,000
Q2 2023

Jul 20, 2023

BUY
$63.71 - $70.74 $35,359 - $39,260
555 Added 17.03%
3,814 $244,000
Q1 2023

Apr 06, 2023

SELL
$65.71 - $74.53 $92,059 - $104,416
-1,401 Reduced 30.06%
3,259 $226,000
Q4 2022

Jan 13, 2023

BUY
$68.48 - $81.09 $20,954 - $24,813
306 Added 7.03%
4,660 $335,000
Q3 2022

Oct 12, 2022

SELL
$0.13 - $76.84 $14,454 - $8.54 Million
-111,186 Reduced 96.23%
4,354 $310,000
Q2 2022

Jul 21, 2022

SELL
$72.62 - $79.98 $8.08 Million - $8.89 Million
-111,200 Reduced 96.24%
4,340 $334,000
Q2 2022

Jul 21, 2022

BUY
$72.62 - $79.98 $7.96 Million - $8.76 Million
109,558 Added 1831.46%
115,540 $223,000
Q1 2022

Apr 14, 2022

SELL
$61.48 - $73.72 $22,378 - $26,834
-364 Reduced 5.74%
5,982 $437,000
Q4 2021

Feb 02, 2022

SELL
$53.63 - $62.52 $845,423 - $985,565
-15,764 Reduced 71.3%
6,346 $396,000
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $88,577 - $103,757
-1,497 Reduced 6.34%
22,110 $1.31 Million
Q2 2021

Jul 13, 2021

BUY
$61.91 - $67.42 $82,464 - $89,803
1,332 Added 5.98%
23,607 $1.58 Million
Q1 2021

Apr 19, 2021

SELL
$59.34 - $66.74 $104,438 - $117,462
-1,760 Reduced 7.32%
22,275 $1.41 Million
Q4 2020

Jan 15, 2021

SELL
$57.74 - $65.43 $127,778 - $144,796
-2,213 Reduced 8.43%
24,035 $1.49 Million
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $24,637 - $27,301
429 Added 1.66%
26,248 $1.58 Million
Q2 2020

Jul 27, 2020

SELL
$54.82 - $64.09 $1.1 Million - $1.29 Million
-20,127 Reduced 43.81%
25,819 $1.52 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $1.02 Million - $1.49 Million
22,039 Added 92.19%
45,946 $2.56 Million
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $1.18 Million - $1.53 Million
23,907 New
23,907 $1.54 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Aurora Private Wealth, Inc. Portfolio

Follow Aurora Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aurora Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aurora Private Wealth, Inc. with notifications on news.